好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Botulinum Toxin, Type A (BoNT-A) for the Treatment of Cervicalgia and Cervicogenic Headache: Results of a Single Center, Randomized, Double-Blind, Active Placebo-Controlled Trial
Headache and Pain
(-)
189
Authors/Disclosures
Mark J. Stillman, MD, FAAN (Insight Clinical Trials LLC) No disclosure on file
Neil Cherian, MD (Cleveland Clinic) Dr. Cherian has nothing to disclose.
No disclosure on file
John G. Oas, MD No disclosure on file
No disclosure on file
Maryann Mays, MD, FAAN (Cleveland Clinic) Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
No disclosure on file